Literature DB >> 33504774

Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA.

Fatima Rizvi1, Elissa Everton1, Anna R Smith1, Hua Liu1, Elizabeth Osota1, Mitchell Beattie2, Ying Tam2, Norbert Pardi3, Drew Weissman3, Valerie Gouon-Evans4.   

Abstract

Induction of intrinsic liver regeneration is an unmet need that can be achieved by temporally activating key hepatocyte regenerative pathways. Here, we establish an efficient, safe, non-integrative method to transiently express hepatocyte-growth-factor (HGF) and epidermal-growth-factor (EGF) in hepatocytes via nucleoside-modified, lipid-nanoparticle-encapsulated mRNA (mRNA-LNP) delivery in mice. We confirm specific hepatotropism of mRNA-LNP via intravenous injection of firefly luciferase encoding mRNA-LNP, with protein expression lasting about 3 days. In the liver, virtually all hepatocytes are transfected along with a subpopulation of endothelial and Kupffer cells. In homeostasis, HGF mRNA-LNP efficiently induce hepatocyte proliferation. In a chronic liver injury mouse model recapitulating non-alcoholic fatty liver disease, injections of both HGF and EGF mRNA-LNP sharply reverse steatosis and accelerate restoration of liver function. Likewise, HGF and EGF mRNA-LNP accelerate liver regeneration after acetaminophen-induced acute liver injury with rapid return to baseline ALT levels. This study introduces mRNA-LNP as a potentially translatable safe therapeutic intervention to harness liver regeneration via controlled expression of endogenous mitogens in vivo.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33504774      PMCID: PMC7840919          DOI: 10.1038/s41467-021-20903-3

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  49 in total

Review 1.  The molecular physiology of liver regeneration following partial hepatectomy.

Authors:  David Mangnall; Nigel C Bird; Ali W Majeed
Journal:  Liver Int       Date:  2003-04       Impact factor: 5.828

Review 2.  Liver regeneration: from myth to mechanism.

Authors:  Rebecca Taub
Journal:  Nat Rev Mol Cell Biol       Date:  2004-10       Impact factor: 94.444

Review 3.  Asialoglycoprotein receptor mediated hepatocyte targeting - strategies and applications.

Authors:  Anisha A D'Souza; Padma V Devarajan
Journal:  J Control Release       Date:  2015-02-18       Impact factor: 9.776

4.  HPLC purification of in vitro transcribed long RNA.

Authors:  Drew Weissman; Norbert Pardi; Hiro Muramatsu; Katalin Karikó
Journal:  Methods Mol Biol       Date:  2013

Review 5.  Liver Regeneration after Acetaminophen Hepatotoxicity: Mechanisms and Therapeutic Opportunities.

Authors:  Bharat Bhushan; Udayan Apte
Journal:  Am J Pathol       Date:  2019-01-14       Impact factor: 4.307

6.  Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms.

Authors:  Akin Akinc; William Querbes; Soma De; June Qin; Maria Frank-Kamenetsky; K Narayanannair Jayaprakash; Muthusamy Jayaraman; Kallanthottathil G Rajeev; William L Cantley; J Robert Dorkin; James S Butler; Liuliang Qin; Timothy Racie; Andrew Sprague; Eugenio Fava; Anja Zeigerer; Michael J Hope; Marino Zerial; Dinah W Y Sah; Kevin Fitzgerald; Mark A Tracy; Muthiah Manoharan; Victor Koteliansky; Antonin de Fougerolles; Martin A Maier
Journal:  Mol Ther       Date:  2010-05-11       Impact factor: 11.454

7.  Pharmacokinetic study of recombinant human hepatocyte growth factor administered in a bolus intravenously or via portal vein.

Authors:  Akio Ido; Akihiro Moriuchi; Ildeok Kim; Masatsugu Numata; Yoshiko Nagata-Tsubouchi; Satoru Hasuike; Hirofumi Uto; Hirohito Tsubouchi
Journal:  Hepatol Res       Date:  2004-11       Impact factor: 4.288

8.  Hepatocyte growth factor, blood clearance, organ uptake, and biliary excretion in normal and partially hepatectomized rats.

Authors:  R Appasamy; M Tanabe; N Murase; R Zarnegar; R Venkataramanan; D H Van Thiel; G K Michalopoulos
Journal:  Lab Invest       Date:  1993-03       Impact factor: 5.662

9.  Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge.

Authors:  Norbert Pardi; Anthony J Secreto; Xiaochuan Shan; Fotini Debonera; Joshua Glover; Yanjie Yi; Hiromi Muramatsu; Houping Ni; Barbara L Mui; Ying K Tam; Farida Shaheen; Ronald G Collman; Katalin Karikó; Gwenn A Danet-Desnoyers; Thomas D Madden; Michael J Hope; Drew Weissman
Journal:  Nat Commun       Date:  2017-03-02       Impact factor: 14.919

10.  Hepatocyte Growth Factor Reduces Free Cholesterol-Mediated Lipotoxicity in Primary Hepatocytes by Countering Oxidative Stress.

Authors:  Mayra Domínguez-Pérez; Natalia Nuño-Lámbarri; Denise Clavijo-Cornejo; Armando Luna-López; Verónica Souza; Leticia Bucio; Roxana U Miranda; Linda Muñoz; Luis Enrique Gomez-Quiroz; Salvador Uribe-Carvajal; María Concepción Gutiérrez-Ruiz
Journal:  Oxid Med Cell Longev       Date:  2016-04-10       Impact factor: 6.543

View more
  13 in total

Review 1.  Nanotechnology-Assisted RNA Delivery: From Nucleic Acid Therapeutics to COVID-19 Vaccines.

Authors:  Chiara Rinoldi; Seyed Shahrooz Zargarian; Pawel Nakielski; Xiaoran Li; Anna Liguori; Francesca Petronella; Dario Presutti; Qiusheng Wang; Marco Costantini; Luciano De Sio; Chiara Gualandi; Bin Ding; Filippo Pierini
Journal:  Small Methods       Date:  2021-07-28

2.  Spatiotemporal expression of HMGB2 regulates cell proliferation and hepatocyte size during liver regeneration.

Authors:  Koichi Yano; Narantsog Choijookhuu; Makoto Ikenoue; Tomohiro Fukaya; Katsuaki Sato; Deokcheol Lee; Noboru Taniguchi; Etsuo Chosa; Atsushi Nanashima; Yoshitaka Hishikawa
Journal:  Sci Rep       Date:  2022-07-13       Impact factor: 4.996

Review 3.  CRISPR somatic genome engineering and cancer modeling in the mouse pancreas and liver.

Authors:  Thorsten Kaltenbacher; Jessica Löprich; Roman Maresch; Julia Weber; Sebastian Müller; Rupert Oellinger; Nina Groß; Joscha Griger; Niklas de Andrade Krätzig; Petros Avramopoulos; Deepak Ramanujam; Sabine Brummer; Sebastian A Widholz; Stefanie Bärthel; Chiara Falcomatà; Anja Pfaus; Ahmed Alnatsha; Julia Mayerle; Marc Schmidt-Supprian; Maximilian Reichert; Günter Schneider; Ursula Ehmer; Christian J Braun; Dieter Saur; Stefan Engelhardt; Roland Rad
Journal:  Nat Protoc       Date:  2022-03-14       Impact factor: 17.021

Review 4.  From Recoding to Peptides for MHC Class I Immune Display: Enriching Viral Expression, Virus Vulnerability and Virus Evasion.

Authors:  John F Atkins; Kate M O'Connor; Pramod R Bhatt; Gary Loughran
Journal:  Viruses       Date:  2021-06-27       Impact factor: 5.048

5.  Transient yet Robust Expression of Proteins in the Mouse Liver via Intravenous Injection of Lipid Nanoparticle-encapsulated Nucleoside-modified mRNA.

Authors:  Elissa Everton; Fatima Rizvi; Anna R Smith; Mitchell Beattie; Ying Tam; Norbert Pardi; Drew Weissman; Valerie Gouon-Evans
Journal:  Bio Protoc       Date:  2021-10-05

6.  DOCK2 regulates antifungal immunity by regulating RAC GTPase activity.

Authors:  Xiaojian Ma; Xi Tan; Bingbing Yu; Wanwei Sun; Heping Wang; Huijun Hu; Yanyun Du; Ruirui He; Ru Gao; Qianwen Peng; Zhihui Cui; Ting Pan; Xiong Feng; Junhan Wang; Chengqi Xu; Bin Zhu; Wei Liu; Chenhui Wang
Journal:  Cell Mol Immunol       Date:  2022-01-25       Impact factor: 22.096

Review 7.  Chemically modified mRNA beyond COVID-19: Potential preventive and therapeutic applications for targeting chronic diseases.

Authors:  Dana Elkhalifa; Menatallah Rayan; Ahmed T Negmeldin; Abdelbary Elhissi; Ashraf Khalil
Journal:  Biomed Pharmacother       Date:  2021-10-28       Impact factor: 6.529

8.  Efficient healing of large osseous segmental defects using optimized chemically modified messenger RNA encoding BMP-2.

Authors:  Rodolfo E De La Vega; Martijn van Griensven; Wen Zhang; Michael J Coenen; Christopher V Nagelli; Joseph A Panos; Carlos J Peniche Silva; Johannes Geiger; Christian Plank; Christopher H Evans; Elizabeth R Balmayor
Journal:  Sci Adv       Date:  2022-02-16       Impact factor: 14.136

Review 9.  Regulatory guidelines and preclinical tools to study the biodistribution of RNA therapeutics.

Authors:  P Vervaeke; S E Borgos; N N Sanders; F Combes
Journal:  Adv Drug Deliv Rev       Date:  2022-03-26       Impact factor: 17.873

Review 10.  The Pivotal Role of Chemical Modifications in mRNA Therapeutics.

Authors:  Albert Liu; Xiao Wang
Journal:  Front Cell Dev Biol       Date:  2022-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.